Sardi A, Bolton J S, Mitchell W T, Merritt C R
Department of Surgery, Ochsner Clinic, New Orleans, Louisiana 70121.
Surg Gynecol Obstet. 1992 Dec;175(6):563-8.
Fine needle aspiration (FNA) biopsy in conjunction with ultrasonic definition of nonpalpable masses in the neck region is being used more frequently. Currently available preoperative localization tests have failed, in many instances, to delineate adequately the location of missed adenomas of the parathyroid gland. We describe herein the use of ultrasonically guided FNA of parathyroid tissue with immunoperoxidase confirmation for precise localization of the diseased gland. Three patients with persistent hypercalcemia after exploration of the neck were referred to Ochsner Clinic, New Orleans. In two of these patients, a parathyroid adenoma had been removed, while in one patient no adenoma was found. All patients had elevated calcium (range 10.9 to 11.6 milligrams per deciliter), low phosphorous and elevated parathyroid levels. Preoperative ultrasonography to localize the suspected parathyroid glands was performed, with FNA and immunohistochemical confirmation. Smears confirmed adequate cellular material. Alcohol fixed, Papanicolaou stained and air dried, Wright's and Giemsa stained smears were evaluated for the presence of parathyroid cells by conventional cytologic examination. The Papanicolaou-stained slides were then decolorized in 1 percent hydrochloric acid in 70 percent ethanol. After decolorization, the smears were stained for parathyroid hormone (PTH) in an avidin-biotin complex (ABC) system, using a commercially available ABC kit (Vector Laboratories Inc.). The primary antibody is a polyclonal antiserum generated in rabbits against a synthetic human PTH. Negative controls were obtained from normal thyroid glands. In all three patients, the diseased gland was localized by ultrasound with cytologic and immunohistochemical confirmation, one on the right side and two on the left side. At surgical excision, the adenomas weighed 0.8 and 0.75 gram and the carcinoma, 0.75 gram. In two, intraoperative identification of the diseased gland was aided by ultrasound directed methylene blue injection into the adenoma. During a follow-up evaluation of eight to 24 months, serum calcium had remained normal in two patients, and one patient had become hypocalcemic and required calcium supplements. The preoperative localization allowed a direct surgical approach to the side in question in all patients. Ultrasonically guided FNA in an immunoperoxidase system can be a valuable preoperative localization technique for patients with recurrent hyperparathyroidism, thus avoiding extensive exploration of the neck with the subsequent complications.
细针穿刺抽吸活检(FNA)联合颈部区域不可触及肿块的超声定位正越来越频繁地被使用。目前可用的术前定位检查在许多情况下都未能充分明确甲状旁腺腺瘤遗漏的位置。我们在此描述了使用超声引导下甲状旁腺组织的FNA并通过免疫过氧化物酶确认来精确确定病变腺体的位置。三名颈部探查后仍持续高钙血症的患者被转诊至新奥尔良的奥施纳诊所。其中两名患者已切除甲状旁腺腺瘤,而一名患者未发现腺瘤。所有患者血钙升高(范围为每分升10.9至11.6毫克),血磷降低,甲状旁腺水平升高。进行术前超声检查以定位可疑的甲状旁腺,并进行FNA和免疫组化确认。涂片证实有足够的细胞材料。对酒精固定、巴氏染色并风干的涂片以及瑞氏和吉姆萨染色的涂片进行常规细胞学检查,以评估甲状旁腺细胞的存在情况。然后将巴氏染色的玻片在70%乙醇中的1%盐酸中脱色。脱色后,使用市售的抗生物素蛋白-生物素复合物(ABC)试剂盒(Vector Laboratories Inc.)在ABC系统中对涂片进行甲状旁腺激素(PTH)染色。一抗是用合成人PTH免疫兔子产生的多克隆抗血清。阴性对照取自正常甲状腺。在所有三名患者中,病变腺体通过超声定位,并经细胞学和免疫组化确认,右侧一例,左侧两例。手术切除时,腺瘤重0.8克和0.75克,癌重0.75克。在两例患者中,术中通过超声引导向腺瘤内注射亚甲蓝辅助识别病变腺体。在8至24个月的随访评估中,两名患者的血清钙保持正常,一名患者出现低钙血症并需要补充钙剂。术前定位使所有患者都能直接对相关侧进行手术。免疫过氧化物酶系统中的超声引导FNA对于复发性甲状旁腺功能亢进患者可能是一种有价值的术前定位技术,从而避免颈部广泛探查及其后续并发症。